by Laura Benjamin | Feb 20, 2025 | News
Myris Therapeutics emerges from stealth to announce new name and strategic focus Proprietary polymer chemistry enables ultra-high drug to antibody ratios of 50 – 100 and new chemical space for precision targeted ADC payloads PITTSBURGH, Feb. 20,...
by Jason Anthony | Jun 4, 2023 | News
Pittsburgh, PA. June 02, 2023 Biohybrid Solutions Holdings, Inc. (BHS), is a biotechnology company using advanced polymer technologies to address outstanding challenges in the development of biologic drugs. BHS’ NanoArmor® technology balances careful tuning of the...
by Jason Anthony | Sep 16, 2022 | News
Pittsburgh, PA. August 09, 2022 We are excited to announce the appointment of Mark Murcko, Ph.D., as our newest Board Member. Mark brings over three decades of industry experience, having been at the center of many transformational biotech efforts and having...
by Jason Anthony | May 4, 2022 | News
Pittsburgh, PA. May 4th, 2022 We are excited to announce the strategic re-structuring of BioHybrid Solutions, LLC (BHS, LLC). BHS, LLC is now a wholly-owned subsidiary of BioHybrid Solutions Holdings, Inc. (BHSH, Inc.). On the heels of this re-structuring, another...
by Jason Anthony | Jan 5, 2022 | News
Pittsburgh, PA, January 5th, 2022– BioHybrid Solutions™ (BHS) is pleased to announce the appointment of Jean Pineault as its new President and Chief Executive Officer effective immediately. Jean, brings a wealth of leadership, experience, and passion to BHS,...
by Jason Anthony | Dec 5, 2019 | News
™Funding from the US Department of Defense will advance the technology towards approval for the protection of America’s military (PITTSBURGH, PA) Dec. 4 BioHybrid Solutions, LLC (BHS), a Pittsburgh-based protein engineering company, announced today that it was awarded...
Recent Comments